跳至主要内容
临床试验/IRCT20210901052359N1
IRCT20210901052359N1招募中2 期

Comparison of the effectiveness of Cannabidiol drop with Pramipexole in Restless Leg Syndrome severity index - randomized parallel clinical trial

Iran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Fulfill RLS criteria based on International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria 2014
  • Normal CBC, serum AST, ALT, Alp, BUN, Cr
  • Serum ferritin level above 50 ng/ml
  • Informed consent

排除标准

  • Taking drugs that have a hepatic metabolism such as warfarin, anticonvulsants, antibiotics
  • Taking dopamine antagonist drugs and other RLS treatment drugs during the past month
  • History of drug abuses and impulse control disorders
  • History of other sleep disorders
  • History of other diseases related to the peripheral and central nervous systems
  • History of cardiovascular, liver, kidney diseases and arrhythmia
  • Pregnancy, lactation and patients using unsafe contraceptive methods
  • Soy allergy

研究者

相似试验